Literature DB >> 21877505

Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.

James Q Del Rosso1.   

Abstract

United States guidelines for the treatment of actinic keratosis (AK) are out of date. A consensus roundtable of 5 thought leaders in dermatology was held in January 2011 to review U.S. and European guidelines and glean from them what seems current and clinically applicable in the management of AK, and subsequently recommend what therapies may need to be added. Current AK treatments, including sequential therapy of various treatment options, and any new agents in development were also taken into consideration.

Entities:  

Mesh:

Year:  2011        PMID: 21877505

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.

Authors:  James Q Del Rosso; Leon Kircik; Gary Goldenberg; Berman Brian
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

Review 2.  Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-12-24       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.